Secnidazole Production Cost Reports

The report provides a detailed analysis essential for establishing a secnidazole production plant. It encompasses all critical aspects necessary for secnidazole production, including the cost of secnidazole production, secnidazole plant cost, secnidazole production costs, and the overall secnidazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a secnidazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Secnidazole is a nitroimidazole antibiotic effective against anaerobic bacteria and certain parasites. It is used to treat bacterial vaginosis (a vaginal infection from bacterial imbalance) and trichomoniasis (a sexually transmitted infection caused by Trichomonas vaginalis). It is used in adults and adolescents aged 12 and older and taken as a convenient single 2g oral dose. It is also applied for amoebiasis (including intestinal and liver forms), giardiasis, and other protozoal infections like acute dysentery, by disrupting microbial DNA to halt growth. It is also used to manage related gastrointestinal and reproductive tract infections. Its common side effects include nausea, vomiting, diarrhoea, abdominal pain, headache, and a metallic or bitter taste in the mouth.

The market for secnidazole is influenced by rising infectious disease cases like bacterial vaginosis, trichomoniasis, amoebiasis, and giardiasis. The expanding healthcare access in developing regions, increased awareness of parasitic treatments, generic drug expansion, and innovations in patient-friendly single-dose formulations boost its demand. The industrial secnidazole procurement is affected by raw material cost volatility, strict regulatory approvals for API quality, and drug resistance risks. Other factors, like supply chain reliance on concentrated Asian producers, competition from generics, and preferences for cost-optimised suppliers amid global healthcare spending growth, affect its sourcing strategies.

Raw Material for Secnidazole Production

According to the secnidazole production plant project report, the key raw materials used in the production of secnidazole include 2-methyl-5-nitroimidazole and propylene oxide.

Production Process of Secnidazole

The extensive secnidazole production cost report consists of the following major industrial production process:

1. From 2-methyl-5-nitroimidazole, propylene oxide: The production process of secnidazole involves reacting 2-methyl-5-nitroimidazole with propylene oxide. The reaction takes place in an organic solvent using a Lewis acid catalyst to form the intermediate. This is followed by the hydrolysis of the aqueous secnidazole solution to yield the crude product. The crude secnidazole is then dissolved in dichloromethane, filtered hot, centrifuged, and dried to obtain pure secnidazole.

Secnidazole is a nitroimidazole antibiotic with the molecular formula C7H11N3O3 and molecular weight of 185.18 g/mol. It appears as a white to beige crystalline powder. It has low water solubility but shows good solubility in DMSO. It has a topological polar surface area of 83.87-83.9 Ų and an XLogP3 value of around 0.98, making it moderately lipophilic. It has three rotatable bonds, one hydrogen bond donor, four acceptors, and collision cross-section values like 137.2 Ų for [M+H]+ in mass spectrometry. It has a pKa value of 3.08 (basic), a heavy atom count of 13, and acts via nitro group reduction, disrupting anaerobic and parasitic DNA.